Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Gretchen E. Glaser"'
Autor:
Diletta Fumagalli, Luigi A. De Vitis, Giuseppe Caruso, Tommaso Occhiali, Emilia Palmieri, Benedetto E. Guillot, Giulia Pappalettera, Carrie L. Langstraat, Gretchen E. Glaser, Evelyn A. Reynolds, Robert Fruscio, Fabio Landoni, Andrea Mariani, Tommaso Grassi
Publikováno v:
Cancers, Vol 16, Iss 7, p 1338 (2024)
Endometrial cancer (EC) is the most diagnosed gynecologic malignancy, and its incidence and mortality are increasing. The prognosis is highly dependent on the disease spread. Surgical staging includes retroperitoneal evaluation to detect potential ly
Externí odkaz:
https://doaj.org/article/ad75606712d746ae86151ad89d9c9b8c
Autor:
Matthew S. Block, Allan B. Dietz, Michael P. Gustafson, Kimberly R. Kalli, Courtney L. Erskine, Bahaaeldin Youssef, Geraldine V. Vijay, Jacob B. Allred, Kevin D. Pavelko, Michael A. Strausbauch, Yi Lin, Megan E. Grudem, Aminah Jatoi, Carolyn M. Klampe, Andrea E. Wahner-Hendrickson, S. John Weroha, Gretchen E. Glaser, Amanika Kumar, Carrie L. Langstraat, Mary L. Solseth, Michael C. Deeds, Keith L. Knutson, Martin J. Cannon
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
The folate receptor alpha (FRα) is overexpressed in the majority of high-grade serous ovarian cancers and has been proposed as a candidate vaccine antigen. Here the authors report the safety and immunogenicity of Th17-inducing dendritic cells pulsed
Externí odkaz:
https://doaj.org/article/a2fbef783d684ad39f4729cec68b77ca
Autor:
Gretchen E Glaser, Gerardo Colon-Otero, Valentina Zanfagnin, Xiaonan Hou, Nathan R Foster, Erik J Asmus, Andrea Wahner Hendrickson, Aminah Jatoi, Matthew S Block, Carrie L Langstraat, Tri A Dinh, Matthew W Robertson, John K Camoriano, Kristina A Butler, John A Copland, S John Weroha
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Objective We describe a phase II clinical trial of the combination of ribociclib and letrozole for treatment of relapsed oestrogen receptor (ER)-positive ovarian cancer (OC) and endometrial cancer (EC). The primary endpoint was the proportion of pati
Externí odkaz:
https://doaj.org/article/ba5b60f9cf5e4b6d8e07c5801f8baa35
Autor:
Larry J. Copeland, Mark F. Brady, Robert A. Burger, William H. Rodgers, Helen Q. Huang, David Cella, David M. O'Malley, Daron G. Street, Krishnansu S. Tewari, David P. Bender, Robert T. Morris, William J. Lowery, David S. Miller, Summer B. Dewdney, Nick M. Spirtos, Shashikant B. Lele, Saketh Guntupalli, Frederick R. Ueland, Gretchen E. Glaser, Robert S. Mannel, Philip J. DiSaia
Publikováno v:
Journal of Clinical Oncology. 40:4119-4128
PURPOSE To compare taxane maintenance chemotherapy, paclitaxel (P) and paclitaxel poliglumex (PP), with surveillance (S) in women with ovarian, peritoneal, or fallopian tube (O/PC/FT) cancer who attained clinical complete response after first-line pl
Autor:
Katherine C. Kurnit, Silvana Pedra Nobre, Bryan M. Fellman, David A. Iglesias, Kristina Lindemann, Anuja Jhingran, Ane Gerda Z. Eriksson, Beyhan Ataseven, Gretchen E. Glaser, Jennifer J. Mueller, Shannon N. Westin, Pamela T. Soliman
Publikováno v:
Gynecologic Oncology. 167:452-457
Uterine serous carcinoma is a rare but aggressive subtype of endometrial adenocarcinoma. Our objective was to compare adjuvant treatment strategies for patients with early stage uterine serous carcinoma.This multi-institutional, retrospective cohort
Autor:
Gretchen E, Glaser, Olivia D, Lara, Bhavana, Pothuri, Carolina Gomez, Grimaldi, Lauren S, Prescott, Spyridon A, Mastroyannis, Sarah, Kim, Adam C, ElNaggar, Diogo, Torres, Lesley B, Conrad, Michaela, McGree, Amy, Weaver, Warner K, Huh, David E, Cohn, S Diane, Yamada, Amanda N, Fader
Publikováno v:
Gynecologic Oncology. 167:146-151
Patients with gynecologic malignancies may have varied responses to COVID-19 infection. We aimed to describe clinical courses, treatment changes, and short-term clinical outcomes for gynecologic oncology patients with concurrent COVID-19 in the Unite
Autor:
Kristina A. Butler, Andrea Mariani, Gretchen E. Glaser, Giovanni Scambia, Emeline Liu, Jvan Casarin, Carrie L. Langstraat, Javier F. Magrina, Yanli Li, Chao Song, Serena Cappuccio, Paul M. Magtibay, Tommaso Grassi
Publikováno v:
International Journal of Gynecologic Cancer. 31:686-693
ObjectiveTo evaluate trends in outpatient versus inpatient hysterectomy for endometrial cancer and assess enabling factors, cost and safety.MethodsIn this retrospective cohort study, patients aged 18 years or older who underwent hysterectomy for endo
Autor:
Leslie Bradford, Gretchen E. Glaser
Publikováno v:
Obstetrics & Gynecology. 137:3-11
Burnout in health care is a public health crisis. Burnout is a triad of emotional exhaustion, depersonalization, and feelings of reduced personal accomplishment. More than half of practicing physicians and trainees experience burnout, and the rates a
Autor:
Gretchen E. Glaser, Giorgia Dinoi, Sean C. Dowdy, Mariam Al Hilli, Amanika Kumar, Amy L. Weaver, Kathleen J. Yost, Andrea Mariani, Andrea L. Cheville, Alyssa Larish, Francesco Multinu, Michaela E. McGree
Publikováno v:
International Journal of Gynecologic Cancer. 31:85-91
ObjectiveEndometrial cancer surgical staging includes lymph node assessment which can lead to lower extremity lymphedema. The aim of this study was to estimate prevalence after sentinel lymph node biopsy versus lymphadenectomy.MethodsConsecutive pati
Autor:
Amanika Kumar, Bahaaeldin Youssef, Yi Lin, Martin J. Cannon, Geraldine V. Vijay, Michael P. Gustafson, Michael A. Strausbauch, Michael C. Deeds, Gretchen E. Glaser, Keith L. Knutson, Courtney L. Erskine, Mary L. Solseth, Matthew S. Block, Allan B. Dietz, Carrie L. Langstraat, Carolyn Klampe, Aminah Jatoi, Kevin D. Pavelko, Andrea E. Wahner-Hendrickson, Kimberly R. Kalli, Megan Grudem, Jacob B. Allred, S. John Weroha
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Nature Communications
Nature Communications
In ovarian cancer (OC), IL-17-producing T cells (Th17s) predict improved survival, whereas regulatory T cells predict poorer survival. We previously developed a vaccine whereby patient-derived dendritic cells (DCs) are programmed to induce Th17 respo